TK216 targets the known oncoprotein, EWS-FLI1

Pre-clinical studies show that TK216 binds to FLI1, blocking it and the other ETS-family transcription factors from forming a protein- DNA complex. The formation of this protein –DNA complex is necessary for the initiation of transcription of proteins that cancer cells need to sustain their uncontrolled growth.